Additionally, studies have indicated that a reduction in SHBG levels contributes to the development of NAFLD, making it a sensitive biomarker of NAFLD [86], and SHBG is suggested as a surrogate marker for insulin resistance in PCOS [93]. Here, SHBG is linked to metabolic dysfunction-associated steatotic liver disease.